Loading... Please wait... Loading... Please wait...
ESTIMATED
07/04/2024
07/04/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
RedHill Biopharma Ltd. last posted its earnings results on Thursday, July 4th, 2024. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.03 by $0.17. The company had revenue of 1.80 M for the quarter and had revenue of 6.51 M for the year. RedHill Biopharma Ltd. has generated $4 earnings per share over the last year ($3.68 diluted earnings per share) and currently has a price-to-earnings ratio of 0.03. RedHill Biopharma Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 4th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 08/17/2023 | Q2 2023 | $0.19 | $23.48 M | $1.80 M | 03/31/2023 | Q1 2023 | $20.44 | $3.60 M | 04/28/2023 | Q4 2022 | $1.07 | $12.80 M | 09/29/2022 | Q3 2022 | -$40.29 | $18.50 M | $17.55 M | 11/07/2022 | Q2 2022 | -$10.04 | $21.50 M | $18.35 M | 03/17/2022 | Q1 2022 | -$16.00 | -$13.36 | 2.64 | $18.24 M | 03/17/2022 | Q4 2021 | -$16.00 | -$19.65 | -3.65 | $22.07 M | 09/29/2021 | Q3 2021 | -$18.28 | $24.51 M | $21.61 M | 06/29/2021 | Q2 2021 | -$24.95 | $24.29 M | $21.50 M | 05/27/2021 | Q1 2021 | -$18.40 | -$21.29 | -2.89 | $20.58 M | 03/18/2021 | Q4 2020 | -$18.00 | -$25.69 | -7.69 | $21.46 M | 09/29/2020 | Q3 2020 | -$19.99 | $25.36 M | $20.94 M | 06/29/2020 | Q2 2020 | -$17.95 | $22.99 M | $20.90 M | 03/04/2020 | Q1 2020 | -$12.80 | -$19.46 | -6.66 | $1.06 M | 03/04/2020 | Q4 2019 | -$12.80 | -$13.89 | -1.09 | $1.59 M | 11/19/2019 | Q3 2019 | -$15.60 | -$13.87 | 1.73 | $1.79 M | $1.40 M | 07/23/2019 | Q2 2019 | -$12.80 | -$15.38 | -2.58 | $2.16 M | $1.56 M | 05/07/2019 | Q1 2019 | -$13.92 | $1.74 M | 02/26/2019 | Q4 2018 | -$15.60 | -$11.68 | 3.92 | $1.36 M | 08/30/2018 | Q3 2018 | -$18.80 | -$17.17 | 1.63 | $2.26 M | $2.21 M |
|---|
A. RedHill Biopharma Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 4th, 2024 based off last year's report dates.
A. The conference call for RedHill Biopharma Ltd.'s latest earnings report can be listened to online.
A. The conference call transcript for RedHill Biopharma Ltd.'s latest earnings report can be read online.
A. RedHill Biopharma Ltd. (NASDAQ:RDHL) has a recorded annual revenue of $6.51 M.
A. RedHill Biopharma Ltd. (NASDAQ:RDHL) has a recorded net income of $6.51 M. RedHill Biopharma Ltd. has generated $3.68 earnings per share over the last four quarters.
A. RedHill Biopharma Ltd. (NASDAQ:RDHL) has a price-to-earnings ratio of 0.03 and price/earnings-to-growth ratio is 0.01.
